ROCKET PHARMACEUTICALS, INC. Earnings Per Share Diluted

Quick Answer

ROCKET PHARMACEUTICALS, INC. reported Earnings Per Share Diluted of $2.01 (loss) per share for the year ending 2025.

  • ROCKET PHARMACEUTICALS, INC. showed an increase of +26.4% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from ROCKET PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), ROCKET PHARMACEUTICALS, INC.'s Earnings Per Share Diluted has declined by 27.2%.
  • Historical annual values: Fiscal year 2025: $2.01 (loss) per share | Fiscal year 2024: $2.73 (loss) per share | Fiscal year 2023: $2.92 (loss) per share | Fiscal year 2022: $3.26 (loss) per share | Fiscal year 2021: $2.67 (loss) per share | Fiscal year 2020: $2.52 (loss) per share | Fiscal year 2019: $1.58 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: